RegentAtlantic Capital’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $8.35M | Sell |
30,095
-489
| -2% | -$138K | 0.25% | 67 |
|
|
2022
Q2 | $8.06M | Sell |
30,584
-122
| -0.4% | -$31.4K | 0.27% | 68 |
|
|
2022
Q1 | $7.36M | Sell |
30,706
-185
| -0.6% | -$43.3K | 0.21% | 86 |
|
|
2021
Q4 | $7.09M | Sell |
30,891
-1,095
| -3% | -$233K | 0.2% | 87 |
|
|
2021
Q3 | $6.4M | Sell |
31,986
-3,544
| -10% | -$771K | 0.19% | 92 |
|
|
2021
Q2 | $8.42M | Sell |
35,530
-1,337
| -4% | -$334K | 0.26% | 68 |
|
|
2021
Q1 | $8.91M | Sell |
36,867
-2,741
| -7% | -$611K | 0.3% | 61 |
|
|
2020
Q4 | $8.25M | Sell |
39,608
-5,425
| -12% | -$1.06M | 0.33% | 58 |
|
|
2020
Q3 | $7.63M | Sell |
45,033
-3,092
| -6% | -$544K | 0.34% | 62 |
|
|
2020
Q2 | $9.03M | Buy |
48,125
+2,180
| +5% | +$414K | 0.5% | 42 |
|
|
2020
Q1 | $8.14M | Buy |
45,945
+9,736
| +27% | +$1.89M | 0.63% | 41 |
|
|
2019
Q4 | $7.4M | Buy |
36,209
+13,581
| +60% | +$2.49M | 0.45% | 56 |
|
|
2019
Q3 | $3.44M | Sell |
22,628
-222
| -1% | -$36.1K | 0.23% | 115 |
|
|
2019
Q2 | $3.6M | Sell |
22,850
-1,656
| -7% | -$260K | 0.24% | 107 |
|
|
2019
Q1 | $3.94M | Sell |
24,506
-1,663
| -6% | -$304K | 0.27% | 91 |
|
|
2018
Q4 | $4.97M | Buy |
26,169
+11,540
| +79% | +$2.41M | 0.42% | 72 |
|
|
2018
Q3 | $3.05M | Buy |
14,629
+230
| +2% | +$42.6K | 0.23% | 111 |
|
|
2018
Q2 | $2.45M | Sell |
14,399
-295
| -2% | -$51.1K | 0.21% | 120 |
|
|
2018
Q1 | $2.46M | Sell |
14,694
-135
| -0.9% | -$26.2K | 0.21% | 125 |
|
|
2017
Q4 | $3.01M | Sell |
14,829
-605
| -4% | -$120K | 0.25% | 113 |
|
|
2017
Q3 | $2.88M | Sell |
15,434
-114
| -0.7% | -$20.3K | 0.25% | 115 |
|
|
2017
Q2 | $2.6M | Sell |
15,548
-357
| -2% | -$57.4K | 0.24% | 124 |
|
|
2017
Q1 | $2.33M | Sell |
15,905
-796
| -5% | -$117K | 0.22% | 127 |
|
|
2016
Q4 | $2.23M | Sell |
16,701
-352
| -2% | -$46.1K | 0.22% | 123 |
|
|
2016
Q3 | $2.22M | Sell |
17,053
-185
| -1% | -$24.2K | 0.23% | 117 |
|
|
2016
Q2 | $2.21M | Sell |
17,238
-415
| -2% | -$54.8K | 0.21% | 112 |
|
|
2016
Q1 | $2.42M | Sell |
17,653
-675
| -4% | -$92.7K | 0.27% | 97 |
|
|
2015
Q4 | $2.68M | Sell |
18,328
-526
| -3% | -$72.3K | 0.29% | 100 |
|
|
2015
Q3 | $2.55M | Sell |
18,854
-2,540
| -12% | -$369K | 0.24% | 104 |
|
|
2015
Q2 | $3.47M | Sell |
21,394
-1,545
| -7% | -$213K | 0.31% | 85 |
|
|
2015
Q1 | $2.97M | Buy |
22,939
+1,890
| +9% | +$220K | 0.26% | 102 |
|
|
2014
Q4 | $2.17M | Buy |
21,049
+2,485
| +13% | +$245K | 0.18% | 126 |
|
|
2014
Q3 | $1.68M | Sell |
18,564
-310
| -2% | -$29K | 0.16% | 134 |
|
|
2014
Q2 | $1.74M | Sell |
18,874
-360
| -2% | -$30.9K | 0.16% | 132 |
|
|
2014
Q1 | $1.61M | Sell |
19,234
-1,705
| -8% | -$140K | 0.16% | 133 |
|
|
2013
Q4 | $1.83M | Sell |
20,939
-511
| -2% | -$41.8K | 0.18% | 125 |
|
|
2013
Q3 | $1.65M | Sell |
21,450
-290
| -1% | -$22.6K | 0.18% | 126 |
|
|
2013
Q2 | $1.58M | Buy |
+21,740
| New | +$1.47M | 0.19% | 124 |
|
Other funds holding CI
RegentAtlantic Capital's CI Position: Q3 2022 in Review
RegentAtlantic Capital reduced its Cigna (CI) stake by 1.6% in Q3 2022, selling an estimated $138K and leaving 30,095 shares worth $8.35M. The position accounts for 0.25% of the portfolio, ranked #67.
RegentAtlantic Capital first reported a position in CI in Q2 2013 and has held it in 38 quarters since. The position peaked at $9.03M in Q2 2020. 1,482 funds tracked by Wall St. Rank hold CI as of Q3 2022.
- RegentAtlantic Capital held 30,095 shares of Cigna worth $8.35M as of Q3 2022.
- RegentAtlantic Capital sold 489 Cigna shares in Q3 2022, an estimated $138K.
- Cigna made up 0.25% of RegentAtlantic Capital's portfolio in Q3 2022, its #67 holding.
- RegentAtlantic Capital first reported a position in Cigna in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's Cigna position peaked at $9.03M in Q2 2020.
- 1,482 funds tracked by Wall St. Rank held Cigna as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.